Skip to main content

Doctors protest cost of Vertex cystic fibrosis drug as its scientists prepare to receive $3M 'Oscars of Science' award

By The Boston Globe  
   April 12, 2024

Trikafta, which was approved in 2019 and works for about 90% of patients with the deadly genetic disease, had an annual list price of more than $326,000 in the United States at the end of last year.

Full story

Get the latest on healthcare leadership in your inbox.